| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/16/2010 | US7662773 Natriuretic compounds, conjugates, and uses thereof |
| 02/16/2010 | US7662769 Acetylglucosaminyl transferases; neovascularization inhibitor screening; antibodies; kits |
| 02/16/2010 | US7662642 Method for detection of specific antibodies using ubiquitin fusion proteins |
| 02/16/2010 | US7662641 using the antibodies to detect the presence of the protein; Zven is a human protein expressed in testicular tissue and peripheral blood lymphocytes; stimulate gastrointestinal contractility, gastric emptying, intestinal transit, and treating gastroparesis; may also inhibit Wnt gene; lung tumors |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662628 Method for producing a protein by culturing in culture medium a host cell transfected with a vector comprising a nucleic acid having the given nucleotide sequence; treatment of myocardial necrosis or ischemia reperfusion injuries; gene therapy; inhibits cell death associated with hypoxia, apoptosis |
| 02/16/2010 | US7662627 Adeno-associated virus materials and methods |
| 02/16/2010 | US7662624 Metal-binding therapeutic peptides |
| 02/16/2010 | US7662622 Flea peritrophin nucleic acid molecules |
| 02/16/2010 | US7662620 Stem cell-derived neuron survival factor polypeptides (SDNSF) for use in prevention and treatment of cell proliferative, neurodegenerative and cardiovascular disorders |
| 02/16/2010 | US7662619 Addition of histidine amino acids to the cytoplasmic domains of membrane and viral envelope proteins for the purpose of solubilizing, and/or reconstituting viral envelope proteins in lipid containing vesicles |
| 02/16/2010 | US7662609 E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs |
| 02/16/2010 | US7662608 Transgenic cell line modified to procontinuously produce budding particle for use as model in diagnostic screening and testing; drug monitoring; antitumor agents; viricides |
| 02/16/2010 | US7662592 in vitro biosynthesis; Lactobacillus, Streptococcus, Enterococcus strains |
| 02/16/2010 | US7662591 Nucleic acid sequences having gene transcription regulatory qualities |
| 02/16/2010 | US7662590 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/16/2010 | US7662589 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 02/16/2010 | US7662588 Producing vaccines; cloning and identification of novel outer membrane proteins (OMP); isolating recombinant polypeptides |
| 02/16/2010 | US7662586 host cells; tumor antigens; for treatment, prevention of cancer |
| 02/16/2010 | US7662585 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/16/2010 | US7662584 Inducing an elevated unfolded protein response by using an isolated heterologous nucleic acid endocing a HAC1 protein, a PTC2 protein or an 1re1 protein; secreted therapeutic or an industrial enzyme |
| 02/16/2010 | US7662576 Transient Receptor Potential Cation Channel, Subfamily A, Member 1 (TRPA1) protein; drug screening; organoleptically comparing cooling strength to that of menthol |
| 02/16/2010 | US7662575 identifying Francisella tularensis vaccine candidates. It enables identification of novel vaccine candidates and quality assurance for vaccine batches, assessment of protection in vaccinates and identification of the infecting agent in vaccinates. Mice were first vaccinated with Brucella infections |
| 02/16/2010 | US7662574 Membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, autoimmune sexual and bleeding disorders |
| 02/16/2010 | US7662573 Methods for evaluating osteoarthritis risk |
| 02/16/2010 | US7662552 Identifying vision defects associated with mutation in gamma-s-crystallin gene (GRYGS) |
| 02/16/2010 | US7662548 Method of screening for modulators of HIV infection |
| 02/16/2010 | US7662410 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 02/16/2010 | US7662399 BASB054 polypeptides |
| 02/16/2010 | US7662395 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 02/16/2010 | US7662394 Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence |
| 02/16/2010 | US7662392 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662390 purified Lawsonia intracellularis protein for the detection of antibodies against Lawsonia intracellularis in animals ( pigs) for inducing protective immunity ; drug screening; Porcine proliferative enteropathy; gramnegative bacteria |
| 02/16/2010 | US7662388 Endogenous peptide and active subfragments thereof |
| 02/16/2010 | US7662386 Administering polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene (wt1); tumor-associated antigen in cancer immunotherapy |
| 02/16/2010 | US7662377 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 02/16/2010 | US7662376 sterol transporter polypeptide for use in the treatment of hypercholesterolemia, hyperlipidemia, gall stones, and atherosclerosis; monoclonal or polyclonal antibody or fab or fv fragments that specifically binds the polypeptide having specific amino acid sequence |
| 02/16/2010 | US7662374 Dual-specificity antibody having specificity for both an activated erbB2 receptor and erbB1 dimers, without significant affinity for monomeric EGFr that is not activate; specificity of the antibodies is due to their recognition and binding of activation epitopes; diagnosis, imaging and for treating tumor |
| 02/16/2010 | US7662372 Insect inhibitory lipid acyl hydrolases |
| 02/16/2010 | US7662370 Low-toxicity, long-circulating human interferon-alpha PEGylated mutants |
| 02/16/2010 | US7662369 Stabilized interferon compositions |
| 02/16/2010 | CA2696934A1 Transgenic mice |
| 02/16/2010 | CA2614785C Regulation of antigen presentation |
| 02/16/2010 | CA2402748C Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
| 02/16/2010 | CA2224444C Type f botulinum toxin and use thereof |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/16/2010 | CA2220433C Il-6 activity inhibitor |
| 02/16/2010 | CA2199144C Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 02/16/2010 | CA2177612C Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
| 02/16/2010 | CA2154231C Process for the preparation of a c1-esterase inhibitor concentrate (c1-inh) and concentrate thus obtained, for therapeutic uses |
| 02/11/2010 | WO2010017542A1 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
| 02/11/2010 | WO2010017514A2 Methods of predicting cancer lethality using replikin counts |
| 02/11/2010 | WO2010017500A2 Anti-pancreatic cancer antibodies |
| 02/11/2010 | WO2010017412A1 Novel biomimetic peptoid polymers |
| 02/11/2010 | WO2010017290A1 Müllerian inhibiting substance (mis) analogues |
| 02/11/2010 | WO2010017209A2 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine |
| 02/11/2010 | WO2010017198A2 Fgfr extracellular domain acidic region muteins |
| 02/11/2010 | WO2010017178A1 Treatment or prevention of hepatitis c with immunomodulator compounds |
| 02/11/2010 | WO2010017075A1 Preparation of low molecular weight polylysine and polyornithine in high yield |
| 02/11/2010 | WO2010016766A2 Antibodies recognizing endogenous human lgr5 and/or lgr6 |
| 02/11/2010 | WO2010016760A2 Immunogenic composition for the treatment of bacterial infection |
| 02/11/2010 | WO2010016706A2 Novel use of idbf |
| 02/11/2010 | WO2010016525A1 Immunity inducer |
| 02/11/2010 | WO2010016069A1 A process for preparation of insulin compounds |
| 02/11/2010 | WO2010015938A2 Use of agonists of integrin alpha 5 for inducing the osteogenic differentiation of mesenchymal stem cells |
| 02/11/2010 | WO2010015899A2 Novel method to generate meganucleases with altered characteristics |
| 02/11/2010 | WO2010015714A1 Mutant alpha-synuclein, and methods using same |
| 02/11/2010 | WO2010015709A2 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof |
| 02/11/2010 | WO2010015421A1 Use of conkunitzin-s1 for the modulation of glucose-induced insulin secretion |
| 02/11/2010 | WO2010015419A2 Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof |
| 02/11/2010 | WO2010015090A1 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 02/11/2010 | WO2010015087A1 Method of inducing stem cell differentiation |
| 02/11/2010 | WO2010015079A1 Optimized promoter sequence |
| 02/11/2010 | WO2010015036A1 Biological applications of steroid binding domains |
| 02/11/2010 | WO2009153518A3 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 02/11/2010 | WO2009136298A3 Compositions and methods for inhibiting shiga toxin and shiga-like toxin |
| 02/11/2010 | WO2009131395A3 Angiogenic peptide |
| 02/11/2010 | WO2005037987A3 Isolated nucleotide sequences responsible for the tomato high pigment-1 mutant phenotypes (hp-1 and hp-1w) and uses thereof |
| 02/11/2010 | US20100037352 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 02/11/2010 | US20100037348 Nucleotide sequences coding insecticidal protein for use in transformation and generation of plants resistant to lepidopteran or coleopteran pest; pesticides; biological pest control |
| 02/11/2010 | US20100037329 Development of sensitive fret sensors and methods of using the same |
| 02/11/2010 | US20100036100 T cell proteins and nucleotides encoding the same |
| 02/11/2010 | US20100036099 Soluble canola protein isolate production ("nutratein") |
| 02/11/2010 | US20100036098 Biocomposites and methods of making the same |
| 02/11/2010 | US20100036097 Mutant Interleukin-2 (IL-2) Polypeptides |
| 02/11/2010 | US20100036096 Compositions and methods for producing recombinant proteins |
| 02/11/2010 | US20100036095 Human CD59 mutants with modulated complement binding activity |
| 02/11/2010 | US20100036094 Polypeptide Markers for the Diagnosis of Alzheimer's Disease |
| 02/11/2010 | US20100035960 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040 |
| 02/11/2010 | US20100035818 Optimized expression of hpv 52 l1 in yeast |
| 02/11/2010 | US20100035814 N-Terminal Pegylated Prolactin Receptor Molecules |
| 02/11/2010 | US20100035813 Recombinant e-selectin made in insect cells |
| 02/11/2010 | US20100035812 Modified Bovine G-CSF Polypeptides And Their Uses |
| 02/11/2010 | US20100035810 Adiponectin production enhancer |
| 02/11/2010 | US20100035806 Compositions and Methods for Detection and Modulation of T Cell Mediated Immune Responses Against Viral Vectors Utilized for Gene Therapy |
| 02/11/2010 | US20100035804 Polypeptide antagonist |
| 02/11/2010 | US20100035803 Polypeptides and Polynucleotides Encoding the same |
| 02/11/2010 | US20100035802 Particular short-chain peptide cancer drug and its treatment |
| 02/11/2010 | US20100035758 Method for detecting oral squamous-cell carcinoma |